Joshua Hare is Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine. Dr. Hare is a practicing cardiologist with board certifications in cardiology and advanced heart failure and cardiac transplantation. During his research career, he has pioneered the use of allogenic adult cell therapy for multiple disease areas. Under his leadership, and in partnership with many faculty across the University of Miami campus, ISCI developed cell-based therapy programs in cancer biology, cardiology, aging, neonatology, skin diseases, bone diseases, neurologic diseases, ophthalmology, and a program devoted to the ethics of stem cell therapy.

Dr. Hare is the scientific co-founder of Longeveron, Inc., a company devoted to developing biological solutions to aging disorders, including aging frailty. Longeveron has active clinical trial programs for aging frailty, immunosenesence of aging, and Alzheimer’s disease.  Longeveron’s programs have been funded by the National Institute on Aging and the Alzheimer’s association.

Educated at the University of Pennsylvania (1984), Johns Hopkins University School of Medicine (1988), The Brigham and Women’s Hospital (1994), and Harvard Medical School, Dr. Hare spent 12 years on the faculty at Johns Hopkins University School of Medicine where he rose to the rank of Professor of Medicine and Biomedical Engineering, and Director of the Cardiac Transplant and Heart Failure program in 2004 before joining the faculty at the University of Miami Miller School of Medicine in 2007. Dr. Hare is an elected member of the American Association of Physicians (2011) and the Association of University Cardiologists (2007). Dr. Hare is the inventor of 15 United States patents, and his research discoveries have led to the founding of four biotechnol­ogy companies.

Continue Reading »